Kang HJ - Search Results

1

Novel carbazole inhibits phospho-STAT3 through induction of protein-tyrosine phosphatase PTPN6.

Hou S, Yi YW, Kang HJ, Zhang L, Kim HJ, Kong Y, Liu Y, Wang K, Kong HS, Grindrod S, Bae I, Brown ML. Hou S, et al. Among authors: kang hj. J Med Chem. 2014 Aug 14;57(15):6342-53. doi: 10.1021/jm4018042. Epub 2014 Aug 4. J Med Chem. 2014. PMID: 24978112 Free PMC article.

2

BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity.

Kang HJ, Kim HJ, Kwon SH, Kang BD, Eling TE, Lee SH, Bae I. Kang HJ, et al. Among authors: kang bd. Cancer Chemother Pharmacol. 2008 Sep;62(4):689-97. doi: 10.1007/s00280-007-0657-7. Epub 2007 Dec 12. Cancer Chemother Pharmacol. 2008. PMID: 18074135

3

CR6-interacting factor 1 (CRIF1) regulates NF-E2-related factor 2 (NRF2) protein stability by proteasome-mediated degradation.

Kang HJ, Hong YB, Kim HJ, Bae I. Kang HJ, et al. J Biol Chem. 2010 Jul 9;285(28):21258-68. doi: 10.1074/jbc.M109.084590. Epub 2010 Apr 28. J Biol Chem. 2010. PMID: 20427290 Free PMC article.

4

ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine.

Duong HQ, Kim HJ, Kang HJ, Seong YS, Bae I. Duong HQ, et al. Among authors: kang hj. Oncol Rep. 2012 Jan;27(1):182-8. doi: 10.3892/or.2011.1503. Epub 2011 Oct 12. Oncol Rep. 2012. PMID: 21993922 Free PMC article.

5

Bioactive food components prevent carcinogenic stress via Nrf2 activation in BRCA1 deficient breast epithelial cells.

Kang HJ, Hong YB, Kim HJ, Wang A, Bae I. Kang HJ, et al. Toxicol Lett. 2012 Mar 7;209(2):154-60. doi: 10.1016/j.toxlet.2011.12.002. Epub 2011 Dec 13. Toxicol Lett. 2012. PMID: 22192953 Free PMC article.

6

Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells.

Yi YW, Kang HJ, Kim HJ, Hwang JS, Wang A, Bae I. Yi YW, et al. Among authors: kang hj. Mol Carcinog. 2013 Sep;52(9):667-75. doi: 10.1002/mc.21905. Epub 2012 Apr 4. Mol Carcinog. 2013. PMID: 22488590 Free PMC article.

7

Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells.

Yi YW, Hong W, Kang HJ, Kim HJ, Zhao W, Wang A, Seong YS, Bae I. Yi YW, et al. Among authors: kang hj. J Cell Mol Med. 2013 May;17(5):648-56. doi: 10.1111/jcmm.12046. Epub 2013 Apr 20. J Cell Mol Med. 2013. PMID: 23601074 Free PMC article.

8

Targeting mutant p53 by a SIRT1 activator YK-3-237 inhibits the proliferation of triple-negative breast cancer cells.

Yi YW, Kang HJ, Kim HJ, Kong Y, Brown ML, Bae I. Yi YW, et al. Among authors: kang hj. Oncotarget. 2013 Jul;4(7):984-94. doi: 10.18632/oncotarget.1070. Oncotarget. 2013. PMID: 23846322 Free PMC article.

9

Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine.

Duong HQ, Yi YW, Kang HJ, Hong YB, Tang W, Wang A, Seong YS, Bae I. Duong HQ, et al. Among authors: kang hj. Int J Oncol. 2014 Mar;44(3):959-69. doi: 10.3892/ijo.2013.2229. Epub 2013 Dec 23. Int J Oncol. 2014. PMID: 24366069 Free PMC article.

10

HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction.

Kang HJ, Yi YW, Hong YB, Kim HJ, Jang YJ, Seong YS, Bae I. Kang HJ, et al. Sci Rep. 2014 Dec 3;4:7201. doi: 10.1038/srep07201. Sci Rep. 2014. PMID: 25467193 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,536 results

Search Page

Filters